# Jagsonpal Pharmaceuticals Ltd – FDA Inspection, Apr 3, 2024

Source: https://www.keypedia.com/records/fda_inspections/jagsonpal-pharmaceuticals-ltd/7e7d51c2-8cd1-4a18-8f7e-f5c60968dff4
Source feed: FDA_Inspections

> FDA inspection 1241011 of Jagsonpal Pharmaceuticals Ltd, April 03, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241011
- Company Name: Jagsonpal Pharmaceuticals Ltd
- Inspection Date: 2024-04-03
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)

Company: https://www.keypedia.com/companies/jagsonpal-pharmaceuticals-ltd/822cdba9-5f90-4f50-9080-449809adbe56

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c